Clinical Trial Update: Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

A Phase 3 randomized study comparing flexible-dose vs low-dose Q8003 for postoperative pain after unilateral total knee arthroplasty has completed, assessing ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Q8003

Snippet

Sponsor: QRxPharma Inc. | Conditions: Postoperative Pain | Phase 3 | Status: COMPLETED